Sheng Hwa Chen

Prof. Sheng Hwa Chen

Department of Audiology, Speech and Language Pathology, Asia University
+1

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Journal of Voice
Verified
Journal Article
Closed access
FLFeng-Chuan Lin
Feng-Chuan Lin
SCSheng Hwa Chen
Sheng Hwa Chen
SCSu-Chiu Chen
Su-Chiu Chen
CWChi-Te Wang
Chi-Te Wang
YKYu-Ching Kuo
Yu-Ching Kuo

28 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Wen-Dien ChangWen-Dien Chang
Wen-Dien Chang
SCSheng Hwa Chen
Sheng Hwa Chen
MTMing-Hsui Tsai
Ming-Hsui Tsai
YTYung-An Tsou
Yung-An Tsou
Background: Unilateral vocal palsy (UVFP) affects the voice and swallowing function and could be treated by various materials to achieve improved mucosal wave and better closure during phonation. Injection laryngoplasty is considered an exemplary method for these patients and could be injected as early as possible. We conducted a systematic review and meta-analysis for the subjective and objective outcomes of autologous fat injection laryngoplasty (AFIL) and assessed the effects for patients with UVFP. Methods: We searched studies from PubMed and EBSCO databases with PRISMA appraisal to search for articles about the effects of AFIL on UVFP. The published articles were reviewed according to our inclusion and exclusion criteria. The short- and long-term outcomes of perceptual, acoustic analysis, and quality of life were also analyzed by meta-analysis. Results: Eleven articles were reviewed, and seven studies were selected for meta-analysis. AFIL improves the perceptual outcome and some voice parameters in short-term and long-term results, i.e., jitter, shimmer, and maximal phonation time (MPT). It also significantly improved the voice handicap index (VHI) in the long term, suggesting an increase in quality of life. Conclusions: AFIL is considered a reliable treatment method for UVFP and could even last for over 12 months.

29 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YTYung-An Tsou
Yung-An Tsou
VTVincent Hui-Chi Tien
Vincent Hui-Chi Tien
SCSheng Hwa Chen
Sheng Hwa Chen
LSLiang-Chun Shih
Liang-Chun Shih
TLTzu-Chieh Lin
Tzu-Chieh Lin
Wen-Dien ChangWen-Dien Chang
Wen-Dien Chang
Sulcus vocalis is a frequent cause of glottic insufficiency that leads to incomplete vocal fold closure during phonation. Type II sulcus vocalis is defined as a partial defect of the lamina propria (LP). Treatment with fillers, such as fat or hyaluronic acid (HA), in the vocal folds is widely used, but the duration of effect is variable. Platelet-rich plasma (PRP) can enhance the survival of autologous fat in fat grafting, and also is used to treat sulcus vocalis. This study aimed to compare the effectiveness of autologous fat graft versus fat graft plus PRP to treat type II sulcus vocalis. Thirty-four patients with a voice handicap index (VHI) ≥ 11 were randomized to two groups, which received LP injections of fat graft (n = 17) or fat graft plus PRP (n = 17). At 1 month and 6 months after injection, the VHI decreased significantly in both groups. The fat plus PRP group had better Jitter, Shimmer, and noise to harmonic ratio (NHR) in 1 month and 6 months after surgery. The fat plus PRP group resulted in lower VHI scores one month after surgery, and stroboscopy revealed sustained smaller gaps after six months. These results indicate that a combination of fat graft plus PRP is safe and effective for treating sulcus vocalis type II and associated vocal atrophy.

12 November 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YTYung-An Tsou
Yung-An Tsou
SCSheng Hwa Chen
Sheng Hwa Chen
WWWen-Chieh Wu
Wen-Chieh Wu
MTMing-Hsui Tsai
Ming-Hsui Tsai
DBDavid Bassa
David Bassa
Wen-Dien ChangWen-Dien Chang
Wen-Dien Chang
Laryngopharyngeal reflux disease (LPRD) might be associated with reflux symptoms, and its severity is correlated with the Reflux Symptoms Index. Diagnosis is often challenging because of a lack of accurate diagnostic tools. Although an association between LPRD and gastroesophageal reflux disease (GERD) exists, the extent to which esophageal pressure changes in patients with LPRD with GERD has been unknown. Therefore, this study surveys the clinical assessments and extent of esophageal pressure changes in LRPD patients with various GERD severities, and compares esophageal sphincter pressures between ages, genders, and body mass index (BMI). This observational study assessed patients with LPRD and GERD. High-resolution esophageal manometry was used to gather data pertaining to the area pressure on the upper esophageal sphincter (UES) and lower esophageal sphincter (LES), and the correlation between such pressure and symptom severity was determined. We compared the esophageal pressure of different UES and LES levels in the following categories: gender, age, BMI, and GERD severity. We analyzed correlations between esophageal pressure and clinical assessments among 90 patients with throat globus with laryngitis with LPRD. LPRD was measured using laryngoscopy, and GERD was measured using esophagoscopy and 24 h PH monitoring. There were no significant differences in the clinical assessments among the four grades of GERD. The LPRD patients with serious GERD had a lower UES and LES pressure. The lowest pressure and longer duration of LES and UES were also observed among patients with LPRD of grade D GERD. No significant differences in UES and LES pressures among ages, genders, or BMIs were noted.